Please login to the form below

Not currently logged in
Email:
Password:

Microsoft signs agreement with Merck & Co

Microsoft is to acquire certain assets of Rosetta Biosoftware, a business unit of Rosetta Inpharmatics – a wholly owned subsidiary of Merck & Co

Microsoft is to acquire certain assets of Rosetta Biosoftware, a business unit of Rosetta Inpharmatics – a wholly owned subsidiary of Merck & Co.

The deal will enable Microsoft to enhance its Amalga Life Sciences platform through the incorporation of genetic, genomic, metabolomic and proteomics data management software.

Under the terms of the agreement, Merck will become a customer of the Microsoft Amalga Life Sciences 2009 platform and will provide strategic input to Microsoft.

The acquisition forms part of Merck's strategy to ensure long-term pipeline productivity through improved effectiveness and efficiency of basic research operations.

"This agreement establishes a stable and sustainable platform for the Rosetta Biosoftware technology. In addition, we look forward to collaborating with Microsoft to develop new bioinformatic solutions to enable and expedite drug discovery and development," said Rupert Vessey, vice president, Merck Research Laboratories.

The Amalga Life Sciences platform automates the analysis of massive, heterogeneous research data and provides scientists and researchers across all life sciences with the opportunity to manage, redesign and control research processes.

The deal is due to close at the end of June 2009. Microsoft is looking into hiring key Rosetta Biosoftware staff to fill roles critical to the effective amalgamation of the technology.

3rd June 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Ali Frederic Ben-Amor
Tackling a formidable foe
Ali Frederic Ben-Amor tells how Merck is taking the fight to multiple sclerosis...
Geoff
Cancer care – the power of new technologies
With patient numbers set to soar, how can we make a difference?...
image 1
Redefining communications excellence
How to be heard in today’s multichannel, multistakeholder, multimedia world...

Infographics